ENOV (Enovis) Short Ratio


ENOV Enovis Corp ENOV
64 GF Score
Price $25.75
GF Value $50.16
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Enovis Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

ENOV
64GF Score
Enovis Corp ENOV
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Enovis (ENOV) Overvalued in 2026?

Based on GuruFocus' analysis, Enovis stock appears to be undervalued. The current stock price of $25.75 is trading 48.7% below its estimated GF Value™ of $50.16. GuruFocus considers Enovis to be Possible Value Trap.

Key valuation signals for ENOV:

  • Short Ratio:
  • GF Value™: $50.16 vs. price of $25.75 (48.7% below fair value)
  • GF Score™: 64/100 with 6 warning signs

No single metric tells the full story. See the ENOV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Enovis Business Description

Address 2711 Centerville Road, Suite 400, Wilmington, DE, USA, 19808
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.
64GF Score

Get the complete analysis for ENOV

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$25.75
Price
$50.16
GF Value